help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DORFMÜLLER, P.
Right arrow Articles by HUMBERT, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DORFMÜLLER, P.
Right arrow Articles by HUMBERT, M.

Am. J. Respir. Crit. Care Med., Volume 165, Number 4, February 2002, 534-539

Chemokine RANTES in Severe Pulmonary Arterial Hypertension

PETER DORFMÜLLER, VÉRONIQUE ZARKA, INGRID DURAND-GASSELIN, GIANPAOLA MONTI, KARL BALABANIAN, GILLES GARCIA, FRÉDÉRIQUE CAPRON, AURORE COULOMB-LHERMINÉ, ANNE MARFAING-KOKA, GÉRALD SIMONNEAU, DOMINIQUE EMILIE, and MARC HUMBERT

Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U1 3 1; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine Béclère Hospital, Assistance Publique Hôpitaux de Paris, South-Paris University, Clamart, France

The recent discovery that sporadic and familial primary pulmonary hypertension can be associated with germline mutations of genes encoding receptor members of the transforming growth factor-beta family has focused much attention on cytokines and growth factors in pulmonary vascular disorders. Production of several cytokines has been demonstrated in severe pulmonary arterial hypertension, emphasizing the possible influence of inflammatory mechanisms in this condition. Moreover, perivascular inflammatory cell infiltrates composed of macrophages and lymphocytes have been detected in plexiform lesions of primary pulmonary hypertension. Chemokine RANTES is an important chemoattractant for monocytes and T cells. We therefore hypothesize that chemokine RANTES promotes cell recruitment in the lungs of patients displaying severe pulmonary arterial hypertension. Reverse transcriptase polymerase chain reaction demonstrated elevated RANTES mRNA expression in 10 lung samples from patients with severe pulmonary arterial hypertension, as compared with seven control subjects. In situ hybridization and immunohistochemistry confirmed that endothelial cells were the major source of RANTES within the pulmonary artery wall of the patients. Serial sections analysis showed that RANTES expression was associated with CD45+ inflammatory cell infiltrates. These results support the concept that inflammatory mechanisms play a role in the natural history of pulmonary arterial hypertension.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, A. Trinh, M. Zupan, M. Canuet, L. Grunebaum, A. Brunette, et al.
Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 536 - 543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Spiekerkoetter, C. M. Alvira, Y.-M. Kim, A. Bruneau, K. L. Pricola, L. Wang, N. Ambartsumian, and M. Rabinovitch
Reactivation of {gamma}HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L276 - L289.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Otterdal, A. K. Andreassen, A. Yndestad, E. Oie, W. J. Sandberg, C. P. Dahl, T. M. Pedersen, T. Ueland, L. Gullestad, F. R. Brosstad, et al.
Raised LIGHT Levels in Pulmonary Arterial Hypertension: Potential Role in Thrombus Formation
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 202 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
O. Sanchez, E. Marcos, F. Perros, E. Fadel, L. Tu, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, and S. Eddahibi
Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1041 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Perros, P. Dorfmuller, R. Souza, I. Durand-Gasselin, V. Godot, F. Capel, S. Adnot, S. Eddahibi, M. Mazmanian, E. Fadel, et al.
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
Eur. Respir. J., May 1, 2007; 29(5): 937 - 943.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. N. Lambrecht and L. M. van den Toorn
The pressure mounts on lung dendritic cells
Eur. Respir. J., March 1, 2007; 29(3): 435 - 437.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Perros, P. Dorfmuller, R. Souza, I. Durand-Gasselin, S. Mussot, M. Mazmanian, P. Herve, D. Emilie, G. Simonneau, and M. Humbert
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension
Eur. Respir. J., March 1, 2007; 29(3): 462 - 468.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Sanchez, O. Sitbon, X. Jais, G. Simonneau, and M. Humbert
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
Chest, July 1, 2006; 130(1): 182 - 189.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin
Chronic Thromboembolic Pulmonary Hypertension
Circulation, April 25, 2006; 113(16): 2011 - 2020.
[Full Text] [PDF]

Home page
 ChestHome page
C. D. Cool, S. D. Groshong, J. Oakey, and N. F. Voelkel
Pulmonary Hypertension: Cellular and Molecular Mechanisms
Chest, December 1, 2005; 128(6_suppl): 565S - 571S.
[Full Text] [PDF]

Home page
 ChestHome page
S. M. Kawut, E. M. Horn, K. K. Berekashvili, A. C. Widlitz, E. B. Rosenzweig, and R. J. Barst
von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension
Chest, October 1, 2005; 128(4): 2355 - 2362.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Ogawa, K. Nakamura, H. Matsubara, H. Fujio, T. Ikeda, K. Kobayashi, I. Miyazaki, M. Asanuma, K. Miyaji, D. Miura, et al.
Prednisolone Inhibits Proliferation of Cultured Pulmonary Artery Smooth Muscle Cells of Patients With Idiopathic Pulmonary Arterial Hypertension
Circulation, September 20, 2005; 112(12): 1806 - 1812.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Lu, H. Shimpo, A. Shimamoto, A. J. Chong, C. R. Hampton, D. J. Spring, M. Yada, M. Takao, K. Onoda, I. Yada, et al.
Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats
J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 850 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Itoh, N. Nagaya, S. Murakami, T. Fujii, T. Iwase, H. Ishibashi-Ueda, C. Yutani, M. Yamagishi, H. Kimura, and K. Kangawa
C-type Natriuretic Peptide Ameliorates Monocrotaline-induced Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1204 - 1211.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. M. Bull, C. D. Coldren, M. Moore, S. M. Sotto-Santiago, D. V. Pham, S. P. Nana-Sinkam, N. F. Voelkel, and M. W. Geraci
Gene Microarray Analysis of Peripheral Blood Cells in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 911 - 919.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. K. Damas, K. Otterdal, A. Yndestad, H. Aass, N. O. Solum, S. S. Froland, S. Simonsen, P. Aukrust, and A. K. Andreassen
Soluble CD40 Ligand in Pulmonary Arterial Hypertension: Possible Pathogenic Role of the Interaction Between Platelets and Endothelial Cells
Circulation, August 24, 2004; 110(8): 999 - 1005.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
L. H. Caramuru, N. Y. Maeda, S. P. Bydlowski, and A. A. Lopes
Age-Dependent Likelihood of In Situ Thrombosis in Secondary Pulmonary Hypertension
Clinical and Applied Thrombosis/Hemostasis, July 1, 2004; 10(3): 217 - 223.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Eddahibi, N. Morrell, M-P. d'Ortho, R. Naeije, and S. Adnot
Pathobiology of pulmonary arterial hypertension
Eur. Respir. J., December 1, 2002; 20(6): 1559 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Raychaudhuri, A. Malur, T. L. Bonfield, S. Abraham, R. J. Schilz, C. F. Farver, M. S. Kavuru, A. C. Arroliga, and M. J. Thomassen
The Prostacyclin Analogue Treprostinil Blocks NFkappa B Nuclear Translocation in Human Alveolar Macrophages
J. Biol. Chem., August 30, 2002; 277(36): 33344 - 33348.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Balabanian, A. Foussat, P. Dorfmuller, I. Durand-Gasselin, F. Capel, L. Bouchet-Delbos, A. Portier, A. Marfaing-Koka, R. Krzysiek, A.-C. Rimaniol, et al.
CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1419 - 1425.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society